BridgeBio
North America, California, United States, Palo Alto
Description
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Investor Profile
BridgeBio has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Series B (67%)
- Series Unknown (33%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
